External Source

Jeffrey Weber, Md, Phd: The Impact Of Braf/mek Inhibitors In Melanoma

2016 1:28
Synopsis
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

You Might Also Like

Jeffrey Weber, MD, PhD explains the importance of testing for NRAS as compared with a BRAF Biomarker 1:46
Jeffrey Weber, Md, Phd Explains The Importance Of Testing Fo...
2016
Jeffrey Weber, MD, PhD: The Impact of Moderate Level of Disease Burden 1:11
Jeffrey Weber, Md, Phd: The Impact Of Moderate Level Of Dise...
2016
Jeffrey Weber, MD, PhD provides interpretation of the NEMO trial results 1:26
Jeffrey Weber, Md, Phd Provides Interpretation Of The Nemo T...
2016
Duration of Dual BRAF-MEK Inhibition 6:05
Duration Of Dual Braf-mek Inhibition
2016
Melanoma | Dr. Tony Talebi discusses the treatment of Stage 4 Melanoma with Dr. Jeff Weber. 27:12
Melanoma | Dr. Tony Talebi Discusses The Treatment Of Stage ...
2011
Dr. Weber on Side Effects of Dabrafenib/Trametinib in Melanoma 1:27
Dr. Weber On Side Effects Of Dabrafenib/trametinib In Melano...
2018
Dr. Jeffrey Weber on Potential Breakthrough "Cures" in Melanoma 1:21
Dr. Jeffrey Weber On Potential Breakthrough "cures" In Melan...
2016
Jeffrey Weber, MD, PhD: Factors to Consider When Determining Treatments 1:28
Jeffrey Weber, Md, Phd: Factors To Consider When Determining...
2016
Melanoma: BRAF/MEK-Inhibitors as Adjuvant Therapy 7:23
Melanoma: Braf/mek-inhibitors As Adjuvant Therapy
2018
Sequencing Dual BRAF-MEK Inhibition and Immunotherapy 9:43
Sequencing Dual Braf-mek Inhibition And Immunotherapy
2016
Dr. Jeffrey Weber on CheckMate-064 Trial for Advanced Melanoma 2:18
Dr. Jeffrey Weber On Checkmate-064 Trial For Advanced Melano...
2016
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.